Descripción
Metabolic Fat Loss Optimization – Mounjaro (Tirzepatide) 15 mg
Metabolic Fat Loss Optimization with Mounjaro (Tirzepatide) is an advanced dual-action peptide designed to support effective fat reduction, appetite control, and improved metabolic performance. By activating both GIP and GLP-1 receptors, it enhances insulin sensitivity, regulates glucose metabolism, and significantly reduces hunger signals. This results in a powerful and sustainable approach to body recomposition and long-term metabolic balance.
Key Features of Metabolic Fat Loss Optimization
- Dual GIP and GLP-1 receptor activation for superior metabolic control
- Strong appetite suppression to support caloric deficit
- Improves insulin sensitivity and glucose utilization
- Promotes consistent and sustainable fat loss
- Supports overall metabolic efficiency and body composition
Dosage Protocol
| Initial Dose | Target Dose | Escalation |
|---|---|---|
| 2.5 mg/week | 5–10 mg/week | Increase every 4 weeks to minimize side effects |
Preparation and Application
- Reconstitute with 2 ml of bacteriostatic water. Gently rotate the vial until fully dissolved.
- Use an insulin syringe: 33 IU = 2.5 mg, 67 IU = 5 mg, 133 IU = 10 mg.
- Inject subcutaneously once weekly in the abdomen, thigh, or upper arm.
- Keep a consistent weekly schedule and rotate injection sites.
- Store refrigerated at 2–8°C and use within 30 days. Do not freeze.
Recommendations to Enhance Effects
Maximize results by maintaining a high-protein intake (1.8–2 g/kg body weight) to preserve lean muscle mass during fat loss. Combine with resistance training 3–4 times per week to support metabolic rate and muscle retention. Focus on nutrient-dense meals rather than extreme caloric restriction, as appetite suppression is already significant. Consistency in lifestyle habits will amplify long-term results.
About Genotech Peptides
We are a molecular bio-engineering laboratory based in Technoparc Montréal, Canada, dedicated to the synthesis of clinical-grade peptides under the most stringent pharmaceutical standards. As part of Quebec’s premier biotechnology cluster, we are committed to ensuring structural integrity and a certified purity exceeding 98% in every lyophilized compound we produce, delivering advanced molecular engineering tools specifically designed for physiological optimization and elite cellular performance.
Legal Notice
This product is intended for adult use only and must be administered under medical supervision. Prior to use, consult a healthcare professional, particularly if you have pre-existing medical conditions or are undergoing concurrent treatments. Use of this product is at your own risk. The manufacturer and distributors assume no liability for improper or unauthorized use.
Advanced Metabolic Control with Mounjaro (Tirzepatide) is a next-generation peptide designed to optimize fat loss, regulate appetite, and improve metabolic efficiency. As a dual GIP and GLP-1 receptor agonist, it enhances insulin sensitivity, slows gastric emptying, and significantly reduces hunger signals. This powerful combination supports sustainable weight management and improved body composition, making it an advanced tool for metabolic optimization protocols.
Key Features of Advanced Metabolic Control with Mounjaro (Tirzepatide)
- Dual-action GIP and GLP-1 receptor activation
- Strong appetite suppression for caloric control
- Enhances insulin sensitivity and glucose regulation
- Promotes efficient fat loss and body recomposition
- Supports long-term metabolic health
Dosage Protocol
| Initial Dose | Target Dose | Escalation |
|---|---|---|
| 2.5 mg/week | 5–10 mg/week | Increase every 4 weeks based on tolerance |
Preparation and Application
- Reconstitute the vial with 2 ml of bacteriostatic water. Gently swirl until fully dissolved.
- Use an insulin syringe: 33 IU = 2.5 mg, 67 IU = 5 mg, 133 IU = 10 mg.
- Administer subcutaneously once per week in the abdomen, thigh, or upper arm.
- Maintain a consistent dosing day each week and rotate injection sites.
- Store refrigerated at 2–8°C and use within 30 days. Do not freeze.
Recommendations to Enhance Effects
To maximize Advanced Metabolic Control with Mounjaro (Tirzepatide), prioritize a high-protein intake (1.8–2 g/kg body weight) to preserve lean muscle mass during fat loss. Incorporate resistance training 3–4 times per week to support metabolic rate and body composition. Avoid excessive caloric restriction, as the peptide already induces a strong appetite reduction. Focus on nutrient-dense foods to ensure adequate micronutrient intake.
About Genotech Peptides
We are a molecular bio-engineering laboratory based in Technoparc Montréal, Canada, dedicated to the synthesis of clinical-grade peptides under the most stringent pharmaceutical standards. As part of Quebec’s premier biotechnology cluster, we are committed to ensuring structural integrity and a certified purity exceeding 98% in every lyophilized compound we produce, delivering advanced molecular engineering tools specifically designed for physiological optimization and elite cellular performance.
Legal Notice
This product is intended for adult use only and must be administered under medical supervision. Prior to use, consult a healthcare professional, particularly if you have pre-existing medical conditions or are undergoing concurrent treatments. Use of this product is at your own risk. The manufacturer and distributors assume no liability for improper or unauthorized use.
Valoraciones
No hay valoraciones aún.